Chemotherapy drugs for patients with stage II bowel cancer can include capecitabine, and patients should follow the doctor’s instruction to cooperate with the treatment.
Bowel cancer is a common malignant tumor of the digestive system, with higher incidence rate of colon cancer and rectal cancer, which can be caused by heredity, bad dietary habits and other factors. After surgery, patients with stage II bowel cancer often need postoperative adjuvant chemotherapy, and capecitabine is one of the drugs in the standard postoperative chemotherapy program for bowel cancer.
Although the efficacy is better, there still exist certain side effects, such as common digestive system manifestations like diarrhea, nausea and vomiting; hand-foot syndrome, which can be manifested as numbness, dullness of sensation, skin swelling and other clinical manifestations; and systemic symptoms such as fatigue and somnolence. Patients do not need to be overly alarmed when such manifestations occur during the application process, and actively cooperate with the doctor’s treatment.